Hanagasi HA - Search Results

1

Late-onset phenotype associated with a homozygous GJC2 missense mutation in a Turkish family.

Kuipers DJS, Tufekcioglu Z, Bilgiç B, Olgiati S, Dremmen MHG, van IJcken WFJ, Breedveld GJ, Mancini GMS, Hanagasi HA, Emre M, Bonifati V. Kuipers DJS, et al. Among authors: hanagasi ha. Parkinsonism Relat Disord. 2019 Sep;66:228-231. doi: 10.1016/j.parkreldis.2019.07.033. Epub 2019 Jul 31. Parkinsonism Relat Disord. 2019. PMID: 31431325

2

Evidence-based pharmacological treatment of dementia.

Emre M, Hanaĝasi HA. Emre M, et al. Among authors: hanagasi ha. Eur J Neurol. 2000 May;7(3):247-53. doi: 10.1046/j.1468-1331.2000.00055.x. Eur J Neurol. 2000. PMID: 10886307 Review.

3

The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa.

Hanağasi HA, Kaptanoglu G, Sahin HA, Emre M. Hanağasi HA, et al. Mov Disord. 2000 Sep;15(5):1016-7. doi: 10.1002/1531-8257(200009)15:5<1016::aid-mds1042>3.0.co;2-j. Mov Disord. 2000. PMID: 11009218 No abstract available.

4

Do unilateral ablative lesions of the subthalamic nucleu in parkinsonian patients lead to hemiballism?

Barlas O, Hanağasi HA, Imer M, Sahin HA, Sencer S, Emre M. Barlas O, et al. Among authors: hanagasi ha. Mov Disord. 2001 Mar;16(2):306-10. doi: 10.1002/mds.1051. Mov Disord. 2001. PMID: 11295786

5

Atypical neurological involvement associated with celiac disease.

Hanagasi HA, Gürol E, Sahin HA, Emre M. Hanagasi HA, et al. Eur J Neurol. 2001 Jan;8(1):67-9. doi: 10.1046/j.1468-1331.2001.00155.x. Eur J Neurol. 2001. PMID: 11509083

6

Stiff leg syndrome: case report.

Gürol ME, Ertas M, Hanagasi HA, Sahin HA, Gürsoy G, Emre M. Gürol ME, et al. Among authors: hanagasi ha. Mov Disord. 2001 Nov;16(6):1189-93. doi: 10.1002/mds.1224. Mov Disord. 2001. PMID: 11748762

7

Therapeutic effects of an acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff's disease.

Sahin HA, Gurvit IH, Bilgiç B, Hanagasi HA, Emre M. Sahin HA, et al. Among authors: hanagasi ha. Clin Neuropharmacol. 2002 Jan-Feb;25(1):16-20. doi: 10.1097/00002826-200201000-00003. Clin Neuropharmacol. 2002. PMID: 11852291 Clinical Trial.

8

Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentials.

Hanagasi HA, Gurvit IH, Ermutlu N, Kaptanoglu G, Karamursel S, Idrisoglu HA, Emre M, Demiralp T. Hanagasi HA, et al. Brain Res Cogn Brain Res. 2002 Aug;14(2):234-44. doi: 10.1016/s0926-6410(02)00110-6. Brain Res Cogn Brain Res. 2002. PMID: 12067696

9

Risk factors for Alzheimer disease: a population-based case-control study in Istanbul, Turkey.

Harmanci H, Emre M, Gurvit H, Bilgic B, Hanagasi H, Gurol E, Sahin H, Tinaz S. Harmanci H, et al. Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17(3):139-45. doi: 10.1097/00002093-200307000-00003. Alzheimer Dis Assoc Disord. 2003. PMID: 14512826

10

Clozapine treatment in oromandibular dystonia.

Hanagasi HA, Bilgic B, Gurvit H, Emre M. Hanagasi HA, et al. Clin Neuropharmacol. 2004 Mar-Apr;27(2):84-6. doi: 10.1097/00002826-200403000-00007. Clin Neuropharmacol. 2004. PMID: 15252269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters